Gros David-Alexandre C
Insider CIK 1644489 · ALNY SVP, Chief Business Officer · ELDN Chief Executive Officer, Director · NBIX President & COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals, In | A Award | 2026-07-31 | 2026-08-04 | 354,454 | — | $0 | 363,454 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | F Tax w/h | 2026-07-31 | 2026-08-04 | 194,791 | $3.38 | $658.4K | 168,663 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | F Tax w/h | 2026-07-31 | 2026-08-04 | 194,791 | $3.38 | $658.4K | 168,663 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award | 2026-07-31 | 2026-08-04 | 354,454 | — | $0 | 363,454 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2025-01-10 | 2025-01-13 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2025-01-10 | 2025-01-13 | 66,500 | — | $0 | 66,500 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2024-11-21 | 2024-11-22 | 1,015,743 | — | $0 | 1,015,743 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 517,454 | — | $0 | 517,454 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-05-01 | 2023-05-02 | 383,299 | — | $0 | 383,299 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-02-01 | 2023-02-02 | 153,600 | — | $0 | 153,600 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-02-01 | 2023-02-02 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2022-02-01 | 2022-02-02 | 108,000 | — | $0 | 108,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2021-12-20 | 2021-12-21 | 2,000 | $4.48 | $9.0K | 9,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2021-08-17 | 2021-08-19 | 4,000 | $6.21 | $24.8K | 7,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2021-06-09 | 2021-06-10 | 3,000 | $8.01 | $24.0K | 3,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2020-09-11 | 2020-09-15 | 18,278 | — | $0 | 18,278 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-02-06 | 2017-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-02-01 | 2017-02-02 | 350,000 | — | $0 | 350,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-12-20 | 2016-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2016-02-22 | 2016-02-24 | 900 | $62.75 | $56.5K | 1,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2016-02-22 | 2016-02-24 | 100 | $62.74 | $6.3K | 100 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-18 | 2015-12-22 | 15,012 | — | $0 | 15,012 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-08 | 2015-06-10 | 140,000 | — | $0 | 140,000 | SEC↗ |